Proof of Concept a major price trigger
Praetorian Research initiates coverage of aresa with a short-term Neutral
rating and long-term Buy rating. Proof of concept for
RedDetect, a plant for detection of landmines, should be
demonstrated within few months. This should pave the way
for capital investments and thereby access for aresa to the
enormous markets for landmine detection, soil pollution and
seed.
For more information, please contact Jesper Ilsøe, Praetorian
Research, tlf: 5025 3000, email: info@p-research.dk
or
Steen Thaarup
CEO
Phone: +45 7022 7747
Mobile: +45 4077 8695
E-mail: st@aresa.dk
The company's certified advisor is Dahl-Sørensen & Partners A/S, Allan Reimann,
tel.: +45 3364 9205.
About Aresa
Aresa is a plant biotech company established in 2001 by the company's current
CSO, Carsten Meier. It originates from the Institute of Molecular Biology at
Copenhagen University.
Aresa focuses on the plant-based technology platform: BioSensor for the
detection of substances in soil, including leakage of explosives from landmines.
Aresa shares are traded at the Nasdaq/OMX-First North stock exchange since the
introduction in 2006. Aresa is based at Symbion Science Park in Copenhagen and
has greenhouse facilities on the outskirts of Copenhagen and test sites in
Denmark, Croatia, and Serbia. Aresa has 11 employees, 7 in research &
development and 2 in landmine operations.
